SARCLISA Patient Profiles
Explore the range of patient types who may be appropriate for treatment with SARCLISA
Newly diagnosed
Relapsed or refractory
Patients with NDMM not eligible for transplant who may be appropriate for SARCLISA + VRd (IMROZ)
Meet Kenneth, a 74-year-old patient who is prioritizing efficacy at 1L
Hypothetical patient case
Patient information
Age
74
ECOG PS
1
R-ISS
II
Cytogenetic risk
Standard
Relevant information
View patient profile
Review the data for SARCLISA + VRd in patients like Kenneth
Explore the IMROZ TrialMeet Mei, a 79-year-old patient who is eager to challenge her high-risk prognosis
Hypothetical patient case
Patient information
Age
79
ECOG PS
2
R-ISS
III
Cytogenetic risk
High
Relevant information
View patient profile
Review the data for SARCLISA + VRd in patients like Mei
Explore the IMROZ TrialRRMM patients who may be appropriate for SARCLISA + Kd (IKEMA)
Meet Maisie, a 68-year-old patient who is motivated to respond to her first relapse
Hypothetical patient case
Patient information
Age
68
ECOG PS
1
Refractory to
lenalidomide
Cytogenetic risk
Standard
Relevant information
View patient profile
Review the data for SARCLISA + Kd in patients like Maisie
Explore the IKEMA TrialMeet Franklin, a 70-year-old patient who is intent on challenging his high-risk prognosis at first relapse
Hypothetical patient case
Patient information
Age
70
Early relapse
(<1 year)
Renal impairment
(eGFR 41 mL/
min/1.73 m2)
High cytogenetic risk
iFISH positive for t(4;14), 1q21+
Relevant information
View patient profile
Review the data for SARCLISA + Kd in patients like Franklin
Explore the IKEMA TrialAn RRMM patient who may be appropriate for SARCLISA + Pd (ICARIA-MM)
Meet Thomas, a 76-year-old patient who is motivated to get back into remission after relapsing for a second time
Hypothetical patient case
Patient information
Age
70
ECOG PS
1
Refractory to
lenalidomide
Renal impairment
(eGFR 44 mL/min/1.73 m2)
Relevant information
View patient profile